Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2014
04/10/2014WO2014053210A1 Pyrrolidines
04/10/2014US20140100254 Radezolid salts and polymorphic forms thereof
04/10/2014US20140100251 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
04/10/2014US20140100226 Oxazole compound and pharmaceutical composition
04/10/2014US20140100224 Neurotrophin mimetics and uses thereof
04/10/2014US20140100223 Compounds and methods for the treatment of isocitrate dehydrogenase related diseases
04/10/2014US20140100216 Stimulators of incretin hormones secretion, method for preparation and use thereof
04/10/2014US20140100214 Heterocyclic compounds and uses thereof
04/10/2014US20140100213 Triazolones as fatty acid synthase inhibitors
04/10/2014US20140100212 Compounds as tyrosine kinase modulators
04/10/2014US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof
04/10/2014US20140100195 Heterobicyclic sphingosine 1-phosphate analogs
04/10/2014US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/10/2014US20140099316 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
04/09/2014EP2716635A1 Compounds which selectively modulate the CB2 receptor
04/09/2014EP2714682A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases
04/09/2014EP2714681A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
04/09/2014EP2714680A1 Heterocyclic autotaxin inhibitors and uses thereof
04/09/2014EP2714678A1 Imidazole derivatives
04/09/2014EP2714667A2 Aminooxazole inhibitors of cyclin dependent kinases
04/09/2014EP2714662A1 Neprilysin inhibitors
04/09/2014EP2714657A1 Morpholino compounds, uses and methods
04/09/2014EP2714654A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/09/2014CN103717605A Spiro-oxindole mdm2 antagonists
04/09/2014CN103717592A Halogen-alkyl-1,3 oxazines as BACE1 and/or BACE2 inhibitors
04/09/2014CN103717591A Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
04/09/2014CN103717589A Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
04/09/2014CN103717586A Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
04/09/2014CN103717582A Isoxazole derivatives useful as antibacterial agents
04/09/2014CN103709155A Preparation method of azilsartan
04/09/2014CN103709154A Benzimidazole derivatives, preparation method and medicinal use thereof
04/09/2014CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs
04/09/2014CN103709116A Preparation method for 4-(4-alkoxycarbonylamino)phenyl-3-morpholine
04/09/2014CN103709115A Pleuromutilin antibiotic derivatives
04/09/2014CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application
04/09/2014CN103709086A Preparation method for ezetimibe optical isomers and intermediate applied in preparation method
04/09/2014CN102712625B Nitrogen-containing heteroaryl derivatives
04/09/2014CN102712596B Secondary 8-hydroxyquinoline-7-carboxamide derivatives
04/09/2014CN102320988B 4-(4-amion phenyl)-3-morpholone intermediate amide and synthesis method and application thereof
04/09/2014CN102164919B Oxazolidinyl antibiotics
04/09/2014CN102106184B Substituted piperidino phenyloxazolidinones
04/08/2014US8691980 Salicylic acid derivatives with fluorophores and method of making and using the same
04/08/2014US8691821 Oxazolidinones as modulators of mGluR5
04/08/2014US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
04/08/2014US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
04/08/2014US8691806 Pyrazole derivatives as protein kinase modulators
04/08/2014US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/08/2014US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
04/08/2014CA2641933C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/08/2014CA2621443C Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
04/03/2014WO2014052896A1 Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
04/03/2014WO2014052619A1 Piperidine derivatives and compositions as modulators of gpr119 activity
04/03/2014WO2014049552A2 Process for the preparation of rivaroxaban
04/03/2014WO2014049512A2 Novel process for preparation of azilsartan medoxomil
04/03/2014WO2014049133A1 New positive allosteric modulators of nicotinic acetylcholine receptor
04/03/2014WO2014048940A2 Nitrogen-containing heterocyclic compounds for plant disease control
04/03/2014WO2014048882A1 Herbicidal and fungicidal 5-oxy-substituted 3-phenylisoxazoline-5-carboxamides and 5-oxy-substituted 3-phenylisoxazoline-5-thioamides
04/03/2014WO2014048853A1 Herbicidally and fungicidally active 3-heteroaryl-isoxazoline-5-carboxamides and 3-heteroaryl-isoxazoline-5-thioamides
04/03/2014WO2014048404A1 A method of preparing a highly pure potassium salt of azilsartan medoxomil
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014047707A1 Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic pain
04/03/2014WO2013053983A8 Protein kinase inhibitors
04/03/2014US20140094480 Pro-Neurogenic Compounds
04/03/2014US20140094474 Androgen receptor modulating carboxamides
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094463 Pharmaceutical Compositions
04/03/2014US20140094462 Sonic hedgehog modulators
04/03/2014US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014CN103703174A Combination pharmaceutical compositions and uses thereof
04/02/2014CN103702995A Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
04/02/2014CN103702993A Benzamides
04/02/2014CN103702983A Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
04/02/2014CN103702979A 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/02/2014CN103702719A Novel fxr (nr1h4) binding and activity modulating compounds
04/02/2014CN103694233A Benzisoxazole compound and application thereof
04/02/2014CN103694232A Monocyclic benzo oxazine intermediate and preparation method and use thereof
04/02/2014CN103694189A Synthesis method of 2-oxazole or 2-thiazole
04/02/2014CN102471264B 5,5-disubstituted-2-imino-pyrrolidine derivatives, preparation methods and pharmaceutical uses thereof
04/02/2014CN102438996B Histone deacetylase inhibitors with branched structure synthesized through click chemistry
04/02/2014CN102264722B Dihydropyridone amides as p2x7 modulators
04/02/2014CN102219785B Triazine-containing benzoxazine, triazine-containing benzoxazine polymer, and preparation method thereof
04/02/2014CN102180872B [1, 3 and 4] oxadiazoles derivative and application thereof
04/01/2014US8686141 Process for preparing N-substituted hydroxypyrimidinone carboxamides
04/01/2014US8686135 Methods of synthesis and purification of heteroaryl compounds
04/01/2014US8686014 Insecticidal compounds
04/01/2014US8686008 Highly selective sigma receptor ligands
04/01/2014US8685975 PDE10 inhibitors and related compositions and methods
04/01/2014US8685971 Quinolinyloxyphenylsulfonamides
04/01/2014US8685970 Quinolines and related analogs as sirtuin modulators
04/01/2014US8685968 Pharmaceutical compounds
04/01/2014CA2749212C Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker
04/01/2014CA2654515C Substituted 3-cyanopyridines as protein kinase inhibitors
04/01/2014CA2619919C Diaminopyrimidines as p2x3 and p2x2/3 modulators
04/01/2014CA2616377C Nitrocatechol derivatives as comt inhibitors
04/01/2014CA2581144C Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/2014
03/27/2014WO2014047392A1 Fluoroalkyl-1,4-benzodiazepinone compounds
03/27/2014WO2014047325A1 Sgc stimulators
03/27/2014WO2014047288A2 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 647